Research · Systematic review
Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement: an updated Cochrane review
What it found
High-certainty evidence of little to no difference from placebo in urinary symptoms (IPSS −0.90, below the meaningful threshold) or quality of life.
- Design
- Systematic review
- Year
- 2024
- Sample size
- 4,656
- Population
- men with lower urinary tract symptoms from benign prostatic enlargement (27 RCTs)
- Intervention
- saw palmetto (Serenoa repens) extract vs placebo
- Outcome
- urological symptom score (IPSS), quality of life, adverse events
- Journal
- World Journal of Men's Health
Citation last checked 2026-06-21.